Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Microcephaly, Delayed speech and language development, and Severe intellectual disability; and common findings: Decreased body weight, Aggressive behavior, Macrotia, and Attention deficit hyperactivity disorder and others. 23 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 6 | Delayed speech and language development, Seizure, Severe intellectual disability |
METTL5 encodes methyltransferase 5, N6-adenosine (209 aa). Catalytic subunit of a heterodimer with TRMT112, which specifically methylates the 6th position of adenine in position 1832 of 18S rRNA. Highest expression in Cells EBV-transformed lymphocytes (65.2 TPM) and Artery Aorta (63.2 TPM).
Intellectual developmental disorder, autosomal recessive 72 is associated with mutations in the METTL5 gene on chromosome 2.
METTL5 is classified as a druggable target with score 0.0.
Genetic testing for METTL5 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 3 always present features, 5 common features.
No clinical trials have been registered for intellectual developmental disorder, autosomal recessive 72.
5 publications have been identified in PubMed for intellectual developmental disorder, autosomal recessive 72. Research spans Epidemiology / Natural History (50%), Review / Meta-Analysis (25%), and Basic Science / Preclinical (25%).
Pan X (2026). [PMID: 41764152](https://pubmed.ncbi.nlm.nih.gov/41764152/). *J Mol Med (Berl)*. [Epidemiology / Natural History]
Hashem S (2025). [PMID: 41465175](https://pubmed.ncbi.nlm.nih.gov/41465175/). *Genes (Basel)*. [Review / Meta-Analysis]
Kuzucu FN (2025). [PMID: 40293582](https://pubmed.ncbi.nlm.nih.gov/40293582/). *Metab Brain Dis*. [Epidemiology / Natural History]
Orji OC (2025). [PMID: 39499421](https://pubmed.ncbi.nlm.nih.gov/39499421/). *Mol Neurobiol*. [Basic Science / Preclinical]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 2:58 PM UTC
Online Mendelian Inheritance in Man
Head and neck | 2 | Microcephaly, Thin upper lip vermilion |
Eyes | 1 | Strabismus |
Heart and blood vessels | 1 | Secundum atrial septal defect |
Muscles | 1 | Generalized hypotonia |
Age of onset: at birth.